|
FBXO33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78423942287509E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.85258491775176E-12 |
| Normal-vs-Stage2 |
1.45329970280272E-10 |
| Normal-vs-Stage3 |
3.98400201717664E-11 |
| Normal-vs-Stage4 |
1.61959999966932E-07 |
| Stage1-vs-Stage2 |
4.555400E-01 |
| Stage1-vs-Stage3 |
4.062000E-01 |
| Stage1-vs-Stage4 |
4.388800E-01 |
| Stage2-vs-Stage3 |
8.054200E-01 |
| Stage2-vs-Stage4 |
6.139800E-01 |
| Stage3-vs-Stage4 |
7.891200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.47055717497824E-13 |
| Normal-vs-AfricanAmerican |
2.136799626129E-10 |
| Normal-vs-Asian |
2.557200E-04 |
| Caucasian-vs-AfricanAmerican |
3.416600E-01 |
| Caucasian-vs-Asian |
6.895600E-01 |
| AfricanAmerican-vs-Asian |
9.331800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69364522406568E-12 |
| Normal-vs-Female |
1.5762002814057E-10 |
| Male-vs-Female |
2.313000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.25379945209647E-10 |
| Normal-vs-Extreme_Weight |
1.6382006862159E-11 |
| Normal-vs-Obese |
5.7065463465733E-14 |
| Normal-vs-Extreme_Obese |
1.07360000001222E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.457800E-01 |
| Normal_Weight-vs-Obese |
5.111000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.309400E-01 |
| Extreme_Weight-vs-Obese |
6.299000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.204200E-01 |
| Obese-vs-Extreme_Obese |
3.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.01819999998432E-08 |
| Normal-vs-Age(41-60Yrs) |
3.87530008083559E-11 |
| Normal-vs-Age(61-80Yrs) |
7.18314296932476E-14 |
| Normal-vs-Age(81-100Yrs) |
1.04480002427465E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.430800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.480400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.375500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.883500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.274000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.635000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.25135490647699E-14 |
| Normal-VS-KIRP CIMP |
1.7523999999991E-06 |
| Normal-VS-Unclassified PRCC |
5.31999999608956E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.446300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.909600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.510200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.355800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.559900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.753800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.51676457452277E-12 |
| Normal-vs-N2 |
2.49379999994748E-06 |
| N0-vs-N1 |
1.176190E-01 |
| N0-vs-N2 |
3.132200E-01 |
| N1-vs-N2 |
3.935800E-02 |
|
|
